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Abstract
Aims The aim of this work is to investigate the accuracy
of the urea breath test (UBT) performed immediately after
emergency endoscopy in peptic ulcer bleeding (PUB).
Methods Urea breath test was carried out right after
emergency endoscopy in patients with PUB. The accuracy
of this early UBT was compared to a delayed one after
hospital discharge that was considered the gold standard.
Clinical and epidemiological factors were analyzed in
order to study their influence on the accuracy of the early
UBT.
Results Early UBT was collected without any complica-
tion and good acceptance from all the 74 patients included.
In 53 of the patients (71.6%), a delayed UBT was obtained.
Comparing concordance between the two tests we have
calculated an accuracy of 83% for the early UBT. Sensi-
bility and specificity were 86.36 and 66%, respectively,
with a positive predictive value of 92.68% and negative
predictive value of 50% (Kappa index = 0.468; p = 0.0005;
CI: 95%). We found no influence of epidemiological fac-
tors, clinical presentation, drugs, times to gastroscopy,
Forrest classification, endoscopic therapy, hemoglobin, and
urea levels over the accuracy of early UBT.
Conclusions Urea breath test carried out right after
emergency endoscopy in PUB is an effective, safe, and
easy-to-perform procedure. The accuracy of the test is not
modified by clinical or epidemiological factors, ulcer stage,
or by the type of therapy applied. However, we have found
a low negative predictive value for early UBT, so a delayed
test is mandatory for all negative cases.
Keywords Breath tests  Endoscopy 
Helicobacter pylori  Peptic bleeding
Introduction
Peptic ulcer is a major cause of gastrointestinal morbidity
and mortality, mainly due to the risk of gastrointestinal
bleeding, which has been estimated to be of 2–3% per year
[1]. Helicobacter pylori (Hp) is the main etiologic agent for
peptic ulcer disease in patients who are not under non-
steroidal anti-inflammatory drugs (NSAIDs) [2]. It has
been proven that correct diagnosis and treatment of this
infection leads to a negligible rate of re-bleeding episodes
[3].
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Although a delayed test can offer a high diagnostic yield
[4], early detection of Hp infection in a bleeding patient
discriminates patients with non-Hp ulcer and can lead to
early therapy [5, 6]; it could save follow-up visits to
diagnosis the infection.
Two large meta-analyses have evaluated the different
methods for Hp detection in peptic ulcer bleeding (PUB)
patients [7, 8]; however, clinical trials in this field have
been scarce in the last years and the associations found by
meta-regressions are observational, and weaker than
derived from randomized comparisons [9].
On the other hand, most studies that analyze diagnostic
tests for Hp detection in a bleeding patient are comparisons
of different tests at the moment of the hemorrhage, which
can result in false-negative tests [10], especially when
invasive methods are used [11]. The accuracy of the urea
breath test (UBT) in PUB patients has not been widely
evaluated taking into account its performance at the
moment of the hemorrhage and once the episode has
resolved (delayed test); moreover, a group of experts have
recently pointed out the importance of addressing this issue
[8].
The aim of our study was to analyze if the diagnostic
yield of UBT performed at the moment of the active
bleeding episode (and as early as possible) is the same of
the UBT once the bleeding has resolved, which is currently
considered to be the best method (and the gold standard)
for the diagnosis of Hp infection [12].
If the diagnostic performance were the same, we would
have a non-invasive, innocuous, safe, and reproducible test
for early diagnosis of Hp infection [13].
Materials and Methods
We have included in this prospective study 18-year-old or
older patients who attended the Department of Gastroen-
terology of the University Hospital of Valladolid with a
bleeding peptic ulcer for a period of 30 months. The study
was approved by the Institutional Review Board of our
institution and informed consent was obtained from the
patients included.
Exclusion criteria were previous upper gastrointestinal
tract surgery, pregnancy or breastfeeding, treatment with
antibiotics, or proton pump inhibitors (PPI) in the previous
4 weeks to the bleeding episode, liver cirrhosis, severe
pulmonary or cardiac dysfunction, chronic renal impair-
ment, or any clinical or psychological situation that
impaired informed consent or the realization of the UBT.
At all times, patients were treated routinely, with fluid
reposition, oxygen and antihistamines, or PPI therapy at
usual dosage. Time from admission to endoscopy was
determined by the clinical condition of the patient. This
time and that from first symptom to admission, form of
presentation of the hemorrhage, age, gender, previous
ulcer history, alcohol (more than 20 g/day), or cigarette
consumption (more than 10 cigarettes/day), and NSAIDs
intake were recorded in a database. Vital signs, hemoglobin
levels, urea levels, and the presence or not of blood at the
naso-gastric tube at admission were also recorded and
analyzed.
Upper endoscopy was performed by an experienced
endoscopist that applied conventional endoscopic therapy
to stop bleeding as needed. No sedation or mild conscious
sedation with midazolam were used; throat anesthesia was
avoided. Invasive tests (rapid urease test or histology) were
collected according to endoscopist criteria in some of the
patients. The location of bleeding ulcers, Forrest classifi-
cation, presence of blood in the stomach, and therapeutic
procedures applied during endoscopy were also recorded.
After emergency endoscopy, UBT for the detection of
Hp was performed by dispensing an oral tablet with
100 mg of C13-labeled urea (UBTest, Otsuka Pharma-
ceutical Europe Ltd , Middlesex, United Kingdom). The
tablet was provided at the endoscopy room once emer-
gency endoscopy had been accomplished. The procedure
was performed following the manufacturer’s instructions:
initially with the patient in a sitting position. After a deep
breath and a short period of apnea, exhaled air was col-
lected. Afterwards, the solid form of C13-labeled urea was
administered orally. The patient was asked to stay 5 min in
a left lateral decubitus position; 20 min later, a second
sample of exhaled air was collected. The two samples were
then sent to a reference laboratory for determination. The
test was considered negative if a value of D13CO2 less than
2. 5% was obtained. No citric acid was used.
After hospital discharge, patients were referred to our
outpatient clinic after 2–4 weeks under PPI therapy. Those
patients who did not have a positive invasive test for Hp were
assessed for Hp status by an ambulatory UBT, performed as
it has been reported previously. PPIs were retired for 2 weeks
before this test. This UBT was considered the gold standard,
as it fulfilled all the requirements for ideal determination:
ambulatory, PPIs retired, and non-active bleeding.
Statistical Analysis
Quantitative variables are presented as mean and standard
deviation. Qualitative variables are presented as percent-
ages. Qualitative variable associations were analyzed by
Pearson’s Chi-square test. Fisher’s exact test and likelihood
ratio were used when needed. Mann–Whitney U test was
used to compare quantitative variables. Concordancy was
assessed by Kappa index. SPSS version 18.0 for Windows
and Epidat 3.1 were used for statistical analysis. A p value
of \0.05 was considered to be statistically significant.
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Results
Seventy-four patients with PUB and a UBT performed
right after emergency endoscopy were included in the
study. UBT was collected without any complication and
good acceptance from all the patients.
In 53 of the patients (71.6%), a delayed ambulatory
UBT was obtained in ideal conditions, showing a preva-
lence of Hp infection of 83%. Of the 21 patients with no
delayed UBT, in 17 an invasive test of Hp diagnosis was
obtained at the moment of endoscopy (histology or rapid
urease test) (Fig. 1). The reasons for not obtaining a
delayed UBT were: a positive invasive test collected at the
moment of endoscopy with the consequent eradication
therapy before the follow-up visit or patients failing to
attend the follow-up visit.
Clinical and epidemiological characteristics of the 53
patients with a delayed UBT are shown in Tables 1 and 2.
Taking into account the 53 patients with two UBT, we
found concordance between the two samples in 44 of them
(38 positive in both samples and six negative in both
cases). In three patients, early UBT was positive with a
negative result in the delayed test and in six patients, the
case was the contrary: negative in the early UBT at
endoscopy and positive in the delayed ambulatory test
(Fig. 1). From all these results we have calculated an
accuracy of 83% for the early UBT. Sensibility and spec-
ificity were 86.36% (75.08–97.64%; CI: 95%) and 66.66%
(30.31–100%; CI: 95%), respectively. The positive pre-
dictive value of the test was 92.68% (83.49–100%; CI:
95%) and the negative predictive value found was 50%
(17.54–82.45%; CI 95%). Kappa index was 0.468 (0.174–
0.761; p = 0.0005; CI: 95%), which means moderate
concordance.
The influence of clinical or epidemiological factors on
the concordance between early and delayed UBT was also
analyzed. We studied age (p = 0.687), sex (p = 0.272),
Fig. 1 Scheme and results of the study. The first ? or - refers to the
early UBT; the second one refers to the delayed UBT in the group of
53 patients and to the invasive test in the group of 21 patients
Table 1 Epidemiological, clinical, and endoscopic characteristics of
the studied patients (qualitative variables) (n = 53)
Gender (%)
Male 62.26
Female 37.74
Tobacco (%)
Smokers 28.30
Non-smokers 71.70
Alcohol (%)
Drinkers 16.98
Non-drinkers 83.02
History of peptic ulcer (%)
Yes 33.97
No 66.03
Non-steroid anti-inflammatory drugs (%)
Yes 45.28
No 54.72
Initial symptom (%)
Hematochezia 3.77
Syncope 11.32
Hematemesis 20.75
Melena 64.16
Drugs until gastroscopy (%)
200 mg PPI 1.89
240 mg PPI 1.89
320 mg PPI 1.89
120 mg PPI 3.77
160 mg PPI 5.66
Anti-H2 7.55
80 mg PPI 11.32
No medication 16.98
40 mg PPI 49.05
Naso-gastric tube (%)
Bilious 1.89
No naso-gastric tube 1.89
Fresh blood 13.21
Coffee grounds 26.41
No blood 56.60
Forrest classification (gastric ulcers) (%)
Forrest IIC 3.77
Forrest IB 5.66
Forrest IIA 7.55
Forrest III 33.96
No gastric ulcer 49.06
Forrest classification (duodenal ulcers) (%)
Forrest IB 1.89
Forrest IIB 3.77
Forrest IIA 5.66
Forrest IIC 7.55
Forrest III 37.73
No duodenal ulcer 43.40
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cigarette smoking (p = 0.701), alcohol consumption
(p = 0.640), previous peptic ulcer (p = 0.701), NSAIDs
intake (p = 0.715), form of clinical presentation of the
hemorrhage (p = 0.372), use of PPI or antihistamines from
admission to endoscopy (p = 0.385), presence of blood in
the nasogastric tube (p = 0.692) or in the stomach
(p = 0.308), Forrest classification in gastric (p = 0.279)
and duodenal ulcers (p = 0.408), type of endoscopic
therapy (p = 0.586), time from first symptom to hospital
admission (p = 0.505), time from admission to endoscopy
(p = 0.543), heart rate (p = 0.152), hemoglobin levels (p =
0.507), and urea levels (p = 0.485). We found no influence
of any of the studied factors over the accuracy of early
UBT in bleeding ulcer patients.
If we include in the study those patients without a
delayed UBT but with an invasive test for Hp infection
obtained at the moment of endoscopy, prevalence of the
infection drops to 77.14%. Accuracy of the early UBT
drops to 78.57%, while sensibility and specificity are
83.33% (72.46–94.19%; CI: 95%) and 62.5% (35.65–
89.34%; CI: 95%), respectively; positive predictive value
is 88.23% (78.41–98.05%) and negative predictive value
found is then 52.63% (27.54–77.71%), with a Kappa index
of 0.430 (0.188–0.671; p = 0.0003; CI 95%). Concordance
remains moderate.
Discussion
Accurate diagnosis of Hp infection in PUB patients leads to
eradication therapy and prevention of relapse [3]. It is
necessary to establish which diagnostic tool is the best in
this setting.
Although several studies have evaluated the prevalence
of Hp in this group of patients, there is no ‘‘gold standard’’
test for its diagnosis [14]. Invasive tests like rapid urease
test show a high rate of false-negative results [7] and UBT
has not been widely used in this setting due to concerns on
its feasibility in patients presenting with nausea and
hematemesis [15]; on the other hand, the sensibility and
specificity of UBT could be lower than usual in PUB
patients [16].
In our group of patients, UBT could be easily performed
with no complications in all patients right after emergency
endoscopy, proving to be a safe and easy to perform test, as
it has been suggested by other authors [17]. Patient
acceptance was also as good as expected [18]. We think
that the solid form of 13C-urea used (tablets) facilitated the
procedure, minimizing the possibility of contamination
with oropharynx bacteria [19] and so reducing the rate of
false-positives [17].
A comprehensive meta-analysis has evaluated the
accuracy of different diagnostic tests for Hp infection in
PUB, proving the superiority of UBT over biopsy-based
methods [7]; however, the analysis is based on studies that
compared different tests obtained at the moment of the
bleeding episode, without a reference or ‘‘gold standard’’
delayed test once the bleeding episode had resolved. Also,
UBT accuracy determination was not the aim of most of
the reviewed studies [17, 20–26].
Another regressive meta-analysis including 8,496
patients has shown that the most significant variable
associated with a high prevalence of Hp infection in PUB is
the use of a delayed diagnostic test [8]; however, accuracy
of every single type of test was not evaluated and only
Table 2 Epidemiological, clinical, and endoscopic characteristics of the studied patients (quantitative variables) (n = 53)
n Minimum Maximum Mean St. deviation
Age (years) 53 24 90 57.85 15.841
Time from symptom to admission (h) 53 2 336 40.30 53.804
Time from admission to gastroscopy (h) 53 1 72 19.79 17.576
Systolic blood pressure (mm/Hg) 53 78 155 124.45 18.513
Diastolic blood pressure (mm/Hg) 53 41 102 72.45 12.834
Cardiac frequency (bpm) 53 60 133 92.47 17.343
Hemoglobin (g/dl) 53 7.3 16.4 10.94 2.691
Urea (mg/dl) 53 18 206 67.30 38.734
Table 1 continued
Blood at stomach when endoscopy (%)
Coffee grounds 5.66
Fresh blood 9.43
No blood 84.91
Endoscopic therapy (%)
Clips 3.77
Clips and sclerosis 5.66
Sclerosis 16.98
No endoscopic therapy 73.59
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eight out of 71 studies included a delayed test. The authors
comment that the results are only observational and that
more studies like the one we have conducted are needed
[8].
Our patients showed a prevalence of Hp infection of
83%, taking as the gold standard the delayed UBT. This
prevalence is somewhat higher than 70–72% obtained in
two meta-analyses in a bleeding population [7, 8] although
similar to that obtained from some studies included in these
meta-analyses (32–100%) and also very similar to that
published in our country by some experts [8, 27]. If we
include for prevalence determination the 17 patients with
no delayed UBT but who had an invasive test performed at
endoscopy, prevalence drops to 77.4%; this fact could be
explained by the high rate of false-negatives for invasive
tests in the setting of a bleeding patient [7].
Sensitivity for early UBT was 86.3%, which is lower
than previously reported in two large meta-analyses in PUB
[7, 16], but within the same range as published in some of
the studies included in this meta-analysis [20–26]; sensi-
tivity for early UBT was higher to 78% reported for UBT in
patients taking PPIs [28]. Tobacco or recent presence of
blood or foods in stomach could have influenced this result
in our patients [16] as well as PPIs from admission to
endoscopy (it is accepted that UBT has a sensitivity higher
than 90% when done in patients withouth PUB).
The specificity found in our study for early UBT was
66.6%, which is lower than that previously reported
(78–100%) [16, 20–26, 29]. An explanation for this
somewhat lower specificity could be the urease activity in
oropharyngeal bacteria [17, 19], which could have been
swept down to the stomach at endoscopy or even due to the
oxygen flow, as well as the occurrence of some borderline
results very close to the selected cut-off value [30] or
maybe differences in sample collection between the early
and the delayed UBT; however, all samples were collected
by a physician either at the moment of endoscopy or at the
outpatient clinic, and changes in the cut-off value would be
expected to have little effect on clinical accuracy of the test
[31]. Some studies have also reported high false-positive
rates for UBT in non-bleeding patients in some specific
settings [32]. We are aware of this limitation of our study,
although other authors have found this unexpected false-
positive rate and low specificity [33]. Technical aspects in
the procedure like pretreatment with citric acid should be
improved in order to increase these suboptimal results [34].
Taking into account the mild severity of side-effects related
to eradication therapy [35], it could be rational to perform
early UBT at endoscopy and eradicate all positive patients,
as empiric therapy in PUB is no longer recommended in
developed countries [36] (although in countries with a very
high prevalence of Hp, empiric therapy could be an option
in terms of cost-effectiveness).
Positive predictive value was 92.8% in our study, which
is similar to or higher than that found in other studies
[7, 16, 37]. This result encourages us to recommend early
UBT in PUB as invasive tests have a low sensitivity [29] in
this group of patients and can be hazardous (for example in
patients under anticoagulant therapy). The unacceptable
negative predictive value found for UBT in our study
highlights the importance of confirming all negative results
using additional tests if possible or in a delayed manner, as
it has been proposed by some authors for invasive tests
[4, 7, 35, 38].
However, we have not found any clinical or epidemio-
logical situation that could modify the accuracy of early
UBT in relation to delayed UBT. It has been proposed that
PPI therapy lowers the sensitivity of UBT [39, 40]; our data
show, as it has been proved for invasive tests [41], that
short courses of acid suppressive therapy, as we used while
the patient was hospitalized, do not alter the performance
of UBT. The presence of blood in the stomach, which is a
limiting factor for invasive tests [34, 42], does not seem to
affect UBT accuracy either, as some authors say [43].
Unlike other studies [8], we did not find that age made any
impact in UBT accuracy. Gender, ulcer location, or NSAID
therapy also did not modify the results, as it has been
previously reported [8, 27].
We are aware of some of the limitations of our study, as
the sample size and lack of control group (UBT after
emergency endoscopy in patients without PUB, but this
was not accepted by the ethics committee). The low
number of Hp-negative patients is also a limitation of our
study but we think this fact only reflects the high rates of
infection in a Spanish population [44]. We did not include
patients with hemodynamic instability because we think
that carrying out UBT in these patients would have been
difficult, even though we are aware that excluding these
patients could reduce the impact of the study. The fact that
we used no sedation or mild sedation was crucial for the
correct realization of the test by the patient.
Although we have included the 17 patients without a
delayed UBT but with an invasive test, comparing different
diagnostic methods was not the aim of our study. We are
aware that determination of Hp status should be assessed
by at least two different methods in clinical trials, although
invasive tests are not always possible in bleeding patients
(needing a quick endoscopy or with coagulopathies in
some cases) and it is assumed the importance of a delayed
test as gold standard for clinical practice [8], as we did. In
any case, it is recommended to perform invasive tests if
possible [36].
It is important to note that in 28.3% of the patients, a
delayed UBT could not be obtained (although in half of
them it was because of being treated previously due to
positive invasive test); this fact emphasizes the value of an
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early diagnosis for Hp infection whatever the test used
because some patients will never attend to the follow-up
visit and could be diagnosed and treated correctly before
hospital discharge.
In conclusion, this study shows that early UBT carried
out right after emergency endoscopy in PUB is an effective,
safe, and easy-to-perform procedure. The accuracy of the
test is not modified by clinical or epidemiological factors,
ulcer stage, or by the type of therapy applied. This approach
can allow early diagnosis and it could be cost-effective,
reducing the number of follow-up visits; also, patients who
will never attend the follow-up visit could be diagnosed and
treated correctly before hospital discharge. However, we
have found a low negative predictive value for early UBT,
so a delayed test is mandatory for all negative cases, as it is
recommended by the International Consensus on Non-
Variceal Upper Gastrointestinal Bleeding.
Conflict of interest None.
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